merged_colon-cancer-blood-test-shield.txt
<question_number>1</question_number>
<answer>Poor record of finding precancerous growths</answer>

<question_number>2</question_number>
<answer>Colonoscopy</answer>

<question_number>3</question_number>
<answer>Simplicity - only requires a blood sample</answer>

<question_number>4</question_number>
<answer>Poor ability to detect precancerous polyps (13% vs 95% with colonoscopy)</answer>

<question_number>5</question_number>
<answer>FDA advisory committee endorsed it despite its inability to prevent cancer because it may increase screening rates</answer>

<question_number>6</question_number>
<answer>Addresses low compliance issues but introduces poor detection of precancerous growths</answer>

<question_number>7</question_number>
<answer>Poor detection of precancerous growths (13% vs 95% with colonoscopy)</answer>

<question_number>8</question_number>
<answer>Simplicity increases accessibility but poor polyp detection creates obstacle to cancer prevention</answer>

<question_number>9</question_number>
<answer>Poor record of finding precancerous growths</answer>

<question_number>10</question_number>
<answer>It may prompt people who forget or avoid colorectal cancer screening to be screened</answer>